Literature DB >> 1717555

Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.

G Dadaglio1, A Leroux, P Langlade-Demoyen, E M Bahraoui, F Traincard, R Fisher, F Plata.   

Abstract

CTL constitute an essential part of the immune response against the HIV. CTL recognize peptides derived from viral proteins together with the MHC class I molecules on the surface of infected cells. The CTL response could be important in prevention or control of infection with HIV by destroying virus-producing cells. In this study we have attempted to identify peptide epitopes recognized by HIV-specific CTL. Using synthetic peptides, we have identified six conserved peptidic epitopes on the gp120 envelope glycoprotein recognized by polyclonal human CTL in association with HLA-A2 class I transplantation Ag. These results were confirmed by two approaches: i) blocking of CTL activities with antibodies specific for three of these conserved peptides; and ii) construction of doubly transfected P815-A2 target cells, using deletions of the HIV env gene. Vaccination or immunotherapy in HLA-A2 individuals can thus be considered using highly conserved HIV env peptidic sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717555

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 2.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 3.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.

Authors:  Irena Kiszka; Dariusz Kmieciak; Jaroslaw Gzyl; Toshio Naito; Elizabeth Bolesta; Aleksander Sieron; Satya P Singh; Alagarsamy Srinivasan; Giorgio Trinchieri; Yutaro Kaneko; Danuta Kozbor
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes.

Authors:  S Chada; C E DeJesus; K Townsend; W T Lee; L Laube; D J Jolly; S M Chang; J F Warner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.

Authors:  R P Johnson; A Trocha; T M Buchanan; B D Walker
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.

Authors:  R P Johnson; S A Hammond; A Trocha; R F Siliciano; B D Walker
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.

Authors:  C Brander; W J Pichler; G Corradin
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities.

Authors:  F Buseyne; G Janvier; B Fleury; D Schmidt; Y Rivière
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.